Leslie Chong
Chief Executive Officer at IMUGENE LIMITED
Net worth: 5 M $ as of 30/04/2024
Leslie Chong active positions
Companies | Position | Start | End |
---|---|---|---|
IMUGENE LIMITED | Director/Board Member | 28/03/2018 | - |
Chief Executive Officer | 01/11/2016 | - | |
Chief Operating Officer | 27/08/2015 | 01/11/2016 |
Career history of Leslie Chong
Former positions of Leslie Chong
Companies | Position | Start | End |
---|---|---|---|
CHIMERIC THERAPEUTICS LIMITED | Director/Board Member | 28/08/2020 | 12/07/2023 |
Independent Dir/Board Member | 28/08/2020 | 12/07/2023 | |
Cure Brain Cancer Foundation
Cure Brain Cancer Foundation Miscellaneous Commercial ServicesCommercial Services Cure Brain Cancer Foundation is a non-profit organization based in Australia that is dedicated to funding innovative brain cancer research. The private company is based in Sydney, Australia. The foundation has invested over $30 million into brain cancer research, including clinical trials and pre-clinical research efforts across pediatric and adult brain cancers. The foundation passionately forges research collaborations, brings world-class clinical trials, and gives people with brain cancer greater access to innovative new treatments. The foundation's mission is to unite the community and rapidly increase brain cancer survival, improving the quality of life for people impacted by the disease, with a vision to ultimately find a cure for brain cancer. The Australian company was founded in 2001. Lance Kawaguchi has been the CEO of the company since 2021. | Director/Board Member | 01/04/2020 | 11/04/2023 |
GSK PLC | Corporate Officer/Principal | - | 01/01/2006 |
EXELIXIS, INC. | Corporate Officer/Principal | - | - |
Pharmaceutical Product Development LLC
Pharmaceutical Product Development LLC Miscellaneous Commercial ServicesCommercial Services Pharmaceutical Product Development LLC engages in the operation of a global contract research organization, which provides drug development, laboratory and lifecycle management services. It offers adaptive trial design, bio analytical lab, bio similar development, biostatistics, GMP lab, clinical supplies, trial monitoring, CMC regulatory, data management, dental pain clinic, real-world outcomes, site intelligence and activation, central lab, global regulatory affairs, IRT systems, late stage research, medical communications, device and diagnostics, medical writing, nonclinical development and regulatory consulting and intelligence, regulatory development, innovation and vaccine sciences. The company was founded by Fredric N. Eshelman in 1985 and is headquartered in Wilmington, NC. | Corporate Officer/Principal | - | - |
Statistics
International
Australia | 4 |
United States | 3 |
United Kingdom | 2 |
Operational
Director/Board Member | 3 |
Corporate Officer/Principal | 3 |
Chief Executive Officer | 1 |
Sectoral
Health Technology | 5 |
Commercial Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 4 |
---|---|
IMUGENE LIMITED | Health Technology |
GSK PLC | Health Technology |
EXELIXIS, INC. | Health Technology |
CHIMERIC THERAPEUTICS LIMITED | Health Technology |
Private companies | 2 |
---|---|
Pharmaceutical Product Development LLC
Pharmaceutical Product Development LLC Miscellaneous Commercial ServicesCommercial Services Pharmaceutical Product Development LLC engages in the operation of a global contract research organization, which provides drug development, laboratory and lifecycle management services. It offers adaptive trial design, bio analytical lab, bio similar development, biostatistics, GMP lab, clinical supplies, trial monitoring, CMC regulatory, data management, dental pain clinic, real-world outcomes, site intelligence and activation, central lab, global regulatory affairs, IRT systems, late stage research, medical communications, device and diagnostics, medical writing, nonclinical development and regulatory consulting and intelligence, regulatory development, innovation and vaccine sciences. The company was founded by Fredric N. Eshelman in 1985 and is headquartered in Wilmington, NC. | Commercial Services |
Cure Brain Cancer Foundation
Cure Brain Cancer Foundation Miscellaneous Commercial ServicesCommercial Services Cure Brain Cancer Foundation is a non-profit organization based in Australia that is dedicated to funding innovative brain cancer research. The private company is based in Sydney, Australia. The foundation has invested over $30 million into brain cancer research, including clinical trials and pre-clinical research efforts across pediatric and adult brain cancers. The foundation passionately forges research collaborations, brings world-class clinical trials, and gives people with brain cancer greater access to innovative new treatments. The foundation's mission is to unite the community and rapidly increase brain cancer survival, improving the quality of life for people impacted by the disease, with a vision to ultimately find a cure for brain cancer. The Australian company was founded in 2001. Lance Kawaguchi has been the CEO of the company since 2021. | Commercial Services |
- Stock Market
- Insiders
- Leslie Chong
- Experience